• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全氟和多氟烷基物质暴露、妊娠体重增加与 Viva 项目产后体重变化。

Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.

机构信息

Population Health Sciences Program, Harvard University, Boston, Massachusetts, USA.

Department of Epidemiology, Berkeley School of Public Health, University of California, Berkeley, California, USA.

出版信息

Obesity (Silver Spring). 2020 Oct;28(10):1984-1992. doi: 10.1002/oby.22933.

DOI:10.1002/oby.22933
PMID:32959518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7513422/
Abstract

OBJECTIVE

The purpose of this study was to test the extent to which pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations were associated with gestational weight gain and postpartum weight changes.

METHODS

This study was composed of 1,614 women recruited between 1999 and 2002 via the Project Viva cohort with pregnancy plasma concentrations of six PFAS, including perfluorooctanesulfonic acid, perfluorooctanoic acid (PFOA), and 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid. Gestational weight gain was defined as the difference between last pregnancy weight and prepregnancy weight, 1-year postpartum weight retention as the difference between 1-year postpartum weight and prepregnancy weight, and 3-year postpartum weight change as the difference between 3-year postpartum weight and prepregnancy weight.

RESULTS

During pregnancy, women gained 0.37 kg (95% CI: 0.11-0.62) more weight per doubling of 2-(N-ethyl-perfluorooctane sulfonamido) acetic acid. At 1 year post partum, women retained 0.55 kg (95% CI: 0.07-1.04) more weight per doubling of PFOA. At 3 years post partum, women gained 0.91 kg (95% CI: 0.25-1.56) more weight per doubling in PFOA. Findings were similar after adjustment for all PFAS. Other PFAS were not associated with weight changes. Postpartum associations were stronger among women with higher prepregnancy BMI. Models were adjusted for demographics.

CONCLUSIONS

Pregnancy PFAS were associated with greater gestational weight gain, weight retention, and weight gain years after pregnancy.

摘要

目的

本研究旨在检验妊娠全氟和多氟烷基物质(PFAS)浓度与妊娠体重增加和产后体重变化的关联程度。

方法

这项研究由 1999 年至 2002 年期间通过 Project Viva 队列招募的 1614 名女性组成,她们的妊娠血浆中有六种 PFAS,包括全氟辛烷磺酸、全氟辛酸(PFOA)和 2-(N-乙基-全氟辛烷磺酰胺基)乙酸。妊娠体重增加定义为最后一次妊娠体重与妊娠前体重的差值,产后 1 年体重保留定义为产后 1 年体重与妊娠前体重的差值,产后 3 年体重变化定义为产后 3 年体重与妊娠前体重的差值。

结果

在妊娠期间,女性的体重每增加一倍 2-(N-乙基-全氟辛烷磺酰胺基)乙酸,体重就会增加 0.37 公斤(95%置信区间:0.11-0.62)。产后 1 年,女性的 PFOA 每增加一倍,体重就会增加 0.55 公斤(95%置信区间:0.07-1.04)。产后 3 年,女性的 PFOA 每增加一倍,体重就会增加 0.91 公斤(95%置信区间:0.25-1.56)。调整所有 PFAS 后,结果仍然相似。其他 PFAS 与体重变化无关。在孕前 BMI 较高的女性中,产后的关联更为强烈。模型调整了人口统计学因素。

结论

妊娠 PFAS 与妊娠体重增加、产后体重保留和产后数年体重增加有关。

相似文献

1
Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.全氟和多氟烷基物质暴露、妊娠体重增加与 Viva 项目产后体重变化。
Obesity (Silver Spring). 2020 Oct;28(10):1984-1992. doi: 10.1002/oby.22933.
2
Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.项目 Viva 中孕期和多氟烷基物质浓度与产后健康:一项前瞻性队列研究。
J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3415-26. doi: 10.1210/clinem/dgaa431.
3
Per- and polyfluoroalkyl substances, gestational weight gain, postpartum weight retention and body composition in the UPSIDE cohort.全氟和多氟烷基物质、妊娠体重增加、产后体重滞留和 UPSIDE 队列的身体成分。
Environ Health. 2023 Sep 2;22(1):61. doi: 10.1186/s12940-023-01009-3.
4
Per- and polyfluoroalkyl substance mixtures and gestational weight gain among mothers in the Health Outcomes and Measures of the Environment study.全氟和多氟烷基物质混合物与健康结果和环境测量研究中母亲的妊娠体重增加。
Int J Hyg Environ Health. 2021 Jan;231:113660. doi: 10.1016/j.ijheh.2020.113660. Epub 2020 Nov 9.
5
Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).早孕期母体外周血中全氟和多氟烷基物质浓度与前瞻性出生队列研究中的母婴甲状腺功能:项目活力(美国)。
Environ Health Perspect. 2018 Feb 27;126(2):027013. doi: 10.1289/EHP2534.
6
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.孕期和哺乳期项目 Viva 中全氟和多氟烷基物质的血浆浓度。
Sci Total Environ. 2023 Sep 15;891:164724. doi: 10.1016/j.scitotenv.2023.164724. Epub 2023 Jun 7.
7
Per- and Polyfluoroalkyl Substances (PFAS) Mixture during Pregnancy and Postpartum Weight Retention in the New Hampshire Birth Cohort Study (NHBCS).新罕布什尔州出生队列研究(NHBCS)中孕期及产后全氟和多氟烷基物质(PFAS)混合物与体重滞留情况
Toxics. 2023 May 10;11(5):450. doi: 10.3390/toxics11050450.
8
Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.糖尿病前期成年人的全氟和多氟烷基物质与血压——糖尿病预防计划结局研究的横断面和纵向分析
Environ Int. 2020 Apr;137:105573. doi: 10.1016/j.envint.2020.105573. Epub 2020 Feb 20.
9
Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.社会人口统计学和围产期因素对孕早期全氟和多氟烷基物质(PFAS)浓度的预测作用
Environ Sci Technol. 2015 Oct 6;49(19):11849-58. doi: 10.1021/acs.est.5b02489. Epub 2015 Sep 11.
10
Postpartum Weight Retention in Primiparous Women and Weight Outcomes in Their Offspring.初产妇产后体重滞留与子代体重结局。
J Midwifery Womens Health. 2019 Jul;64(4):427-434. doi: 10.1111/jmwh.12986. Epub 2019 Jul 12.

引用本文的文献

1
Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances and Gestational Weight Gain: A Systematic Review and Meta-analysis.孕妇血清中全氟和多氟烷基物质的浓度与孕期体重增加:一项系统评价和荟萃分析。
Int J Prev Med. 2025 Jul 30;16:46. doi: 10.4103/ijpvm.ijpvm_139_24. eCollection 2025.
2
Early-pregnancy per- and polyfluoroalkyl substances and maternal post-pregnancy weight trajectory.孕早期全氟和多氟烷基物质与产后体重变化轨迹
Obesity (Silver Spring). 2025 Apr;33(4):807-816. doi: 10.1002/oby.24250. Epub 2025 Mar 12.
3
Associations of maternal per- and polyfluoroalkyl substance plasma concentrations during pregnancy with offspring polycystic ovary syndrome and related characteristics in project viva.

本文引用的文献

1
Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children.孕期母体血清中全氟烷基物质浓度与妊娠体重增加:阿冯纵向父母与子女研究。
Reprod Toxicol. 2019 Dec;90:8-14. doi: 10.1016/j.reprotox.2019.08.003. Epub 2019 Aug 12.
2
Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.全氟烷基和多氟烷基物质与新发糖尿病及微血管疾病的关联。
Diabetes Care. 2019 Sep;42(9):1824-1832. doi: 10.2337/dc18-2254. Epub 2019 Jul 11.
3
Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity.
孕期母体血浆中全氟和多氟烷基物质浓度与项目Viva中后代多囊卵巢综合征及相关特征的关联。
Environ Res. 2025 Mar 1;268:120786. doi: 10.1016/j.envres.2025.120786. Epub 2025 Jan 9.
4
Per- and Polyfluoroalkyl Substances (PFAS) Affect Female Reproductive Health: Epidemiological Evidence and Underlying Mechanisms.全氟和多氟烷基物质(PFAS)对女性生殖健康的影响:流行病学证据及潜在机制
Toxics. 2024 Sep 18;12(9):678. doi: 10.3390/toxics12090678.
5
Early Pregnancy Plasma Per- and Polyfluoroalkyl Substances (PFAS) and Maternal Midlife Adiposity.早期妊娠血浆中的全氟和多氟烷基物质(PFAS)与母亲中年肥胖
J Clin Endocrinol Metab. 2025 May 19;110(6):e1966-e1974. doi: 10.1210/clinem/dgae542.
6
Endocrine disrupting chemicals: gestational diabetes and beyond.内分泌干扰化学物质:妊娠期糖尿病及其他影响
Diabetol Metab Syndr. 2024 Apr 26;16(1):95. doi: 10.1186/s13098-024-01317-9.
7
Effect of Per and Poly-Fluoroalkyl Substances on Pregnancy and Child Development.全氟和多氟烷基物质对妊娠及儿童发育的影响。
Curr Pediatr Rev. 2025;21(2):142-153. doi: 10.2174/0115733963267526231120110100.
8
Per- and polyfluoroalkyl substances, gestational weight gain, postpartum weight retention and body composition in the UPSIDE cohort.全氟和多氟烷基物质、妊娠体重增加、产后体重滞留和 UPSIDE 队列的身体成分。
Environ Health. 2023 Sep 2;22(1):61. doi: 10.1186/s12940-023-01009-3.
9
C57BL/6J mice exposed to perfluorooctanoic acid demonstrate altered immune responses and increased seizures after Theiler's murine encephalomyelitis virus infection.C57BL/6J 小鼠暴露于全氟辛酸后,在感染 Theiler 氏脑脊髓炎病毒后表现出免疫反应改变和癫痫发作增加。
Front Immunol. 2023 Aug 2;14:1228509. doi: 10.3389/fimmu.2023.1228509. eCollection 2023.
10
Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.孕期和哺乳期项目 Viva 中全氟和多氟烷基物质的血浆浓度。
Sci Total Environ. 2023 Sep 15;891:164724. doi: 10.1016/j.scitotenv.2023.164724. Epub 2023 Jun 7.
全氟和多氟烷基物质与肥胖的关联。
JAMA Netw Open. 2018 Aug 3;1(4):e181493. doi: 10.1001/jamanetworkopen.2018.1493.
4
Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study.全氟烷基物质与体重减轻饮食对体重和静息代谢率的影响变化:一项前瞻性研究。
PLoS Med. 2018 Feb 13;15(2):e1002502. doi: 10.1371/journal.pmed.1002502. eCollection 2018 Feb.
5
Perfluoroalkyl acid levels in first-time mothers in relation to offspring weight gain and growth.初产妇体内全氟烷基酸水平与后代体重增加和生长的关系。
Environ Int. 2018 Feb;111:191-199. doi: 10.1016/j.envint.2017.12.002. Epub 2017 Dec 20.
6
Endocrine Disruptors Leading to Obesity and Related Diseases.导致肥胖及相关疾病的内分泌干扰物。
Int J Environ Res Public Health. 2017 Oct 24;14(10):1282. doi: 10.3390/ijerph14101282.
7
Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis.孕期体重增加与母婴结局的关联:一项系统评价和荟萃分析。
JAMA. 2017 Jun 6;317(21):2207-2225. doi: 10.1001/jama.2017.3635.
8
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.通过转录谱分析揭示的全氟烷基酸的PPARα非依赖性转录靶点。
Toxicology. 2017 Jul 15;387:95-107. doi: 10.1016/j.tox.2017.05.013. Epub 2017 May 27.
9
Endocrine Disruptors and Obesity.内分泌干扰物与肥胖
Curr Obes Rep. 2017 Mar;6(1):18-27. doi: 10.1007/s13679-017-0240-4.
10
Persistent organic pollutants alter DNA methylation during human adipocyte differentiation.持久性有机污染物在人类脂肪细胞分化过程中改变DNA甲基化。
Toxicol In Vitro. 2017 Apr;40:79-87. doi: 10.1016/j.tiv.2016.12.011. Epub 2016 Dec 20.